Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

PHASE3CompletedINTERVENTIONAL
Enrollment

811

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Glargine

One daily injection in the evening. 100 U/ml

DRUG

Insulin Glulisine

Given immediately before each of the three main meals. 100 U/ml

DRUG

Metformin

At same dosages as the previous treatment

DRUG

insulin secretagogue

sulfonylurea or glinide

Trial Locations (18)

Unknown

Sanofi-Aventis, Brussels

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Athens

Sanofi-Aventis, Budapest

Sanofi-Aventis, Dublin

Sanofi-Aventis, Milan

Sanofi-Aventis, Vilnius

Sanofi-Aventis, México

Sanofi-Aventis, Gouda

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Moscow

Sanofi-Aventis, Seoul

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Stockholm

Sanofi-Aventis, Taipei

Sanofi-Aventis, Istanbul

Sanofi-Aventis, Guildford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY